TRIUM becomes a member of the new ATMP platform At.las

3 June 2020
< Back to overview

At.las (Leveraging Affordable Solutions for Advanced Therapies) is a young platform, relevant for all stakeholders involved with or passionate about advanced cell or gene therapies. With ATMPs as one of our focus areas, this is a platform we can’t neglect!

Its ambition?

To push innovation, to assist in bringing new products to the patients.


By sharing experiences, spreading know-how and connecting the right people.


Because advanced therapies can help patients for whom there is no cure today.

A mission statement that goes hand-in-hand with the one of TRIUM to be a true partner with a focus on excellence to provide start‐to‐finish clinical trial activities tailored to the timing, budget and specific needs of our clients.